PenMetabolic · GHRH
Tesamorelin 10 mg
The 10 mg GHRH-analog pen for GH-axis and visceral-fat research.
View 10 mg
TESAMORELIN PENMetabolic · GHRH
Tesamorelin 20 mg
Strength 20 mg / 3 mLPurity HPLCForm Pre-filled penCOA Per batch
A stabilised growth-hormone-releasing hormone (GHRH) analog studied for its effects on the GH/IGF-1 axis and visceral-adipose-tissue research models.
Researched directions
- GHRH / GH-axis stimulation research
- Visceral-fat reduction endpoints
- IGF-1 and body-composition models
- Lipid-profile research
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
About Tesamorelin
Tesamorelin is a synthetic GHRH analog studied for stimulating endogenous growth-hormone release, with particular research interest in visceral-adipose-tissue reduction. This 20 mg pen suits higher-concentration designs.
Features
Tesamorelin is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
Related compounds
Back to catalogue Pen
PenMetabolic · GHRH
CJC-1295 10 mg
A GHRH analog studied for sustained growth-hormone-axis stimulation research.
View 10 mg
Every batch, documented.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.